Treatment outcome of patients with anaplastic thyroid cancer: a single center experience.

Yonsei Med J · 2012 · PMC3282954 · PMID 22318823

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

9 Compared with once-daily regimen, a twice-daily fractionation regimen was well tolerated and showed a trend toward improved survival (13.6 months vs. 10.3 months in patients treated with once-daily fractionation).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.